Previous close | 0.13 |
Open | 0.13 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.13 - 7.79 |
52-week range | 0.13 - 38.40 |
Volume | |
Avg. volume | 1,602 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Discover how Jaguar Health Inc is advancing in oncology supportive care and improving financial metrics amidst challenges.
Jaguar Health ( NASDAQ:JAGX ) Full Year 2023 Results Key Financial Results Revenue: US$9.76m (down 18% from FY 2022...
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript April 1, 2024 Jaguar Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Before I turn the call over to management, I’d like to remind you that management may make […]